<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

SCS Boomerangs Back: Q221 Market Report

By Anne Staylor on 9/24/21 9:31 AM

A big boost in Q2 with double-digit gains in all segments.

The US and WW SCS Market boomeranged to pre-COVID levels in Q221 driven by declining COVID-19 cases and ongoing launches of new technologies and products. With easy comps against a quarter that was one of the hardest hit by the pandemic in 2020, Q221 growth was up in the double digits vs Q220 and was up in the low-single digits compared to Q219.

Among the many topics covered in detail in our comprehensive Q221 SCS Market Recap* are:

Continue Reading
2 min read

SmartTRAK heads to Boston for NASS!

By Thomas Wallick on 9/23/21 9:00 AM



The SmartTRAK team is excited to head to Boston for the North American Spine Society (NASS) meeting. Need better business intelligence? Visit us at Booth 3719. SmartTRAK is the most comprehensive business intelligence platform for the MedTech industry. SmartTRAK's real-time data allows everyone in your organization to tap into the same data to drive strategic consistency and increase collaboration across your enterprise. Watch the video below to learn how SmartTRAK can help.


Planning to go to NASS? SmartTRAK will be represented in Boston by:

  • Julianne Burns, GM, Spine
  • Elise Wolf, VP & GM, Orthopedics
  • Kristina Meyer, CCO
  • Matt Golembeski, Dir. of Sales
  • Joe Mish, Dir. of Sales
  • Tim Patrick, Sr. Manager of Corporate Accounts

Meet with us in Boston to learn more about what's coming down the road, including:

  • Integration: Combine our data with yours and integrate it into your data analytic platform.
  • Customization: Tailor SmartTRAK to match your company's business and create your own business intelligence solution.
  • Expanded Functionality: Drive strategic consistency across your enterprise with user-specific enhancements and increase collaboration across your team

Schedule a meeting today!
We know you're going to love what's coming down the road!

Schedule a Meeting

Continue Reading
3 min read

COVID's Silver Lining for Orthopedic Surgery: An Interview with Joseph Bosco lll, MD

By Lisa Mahan on 9/21/21 8:00 AM

At AAOS 2021, outgoing President Joseph Bosco III, MD, shares the positive changes in orthopedics accelerated by COVID-19 from the move of procedures to ASCs to increased use of technology

Joseph Bosco III, MD, vice-chair of clinical affairs for NYU Langone Orthopedics and outgoing president of the American Academy of Orthopedic Surgeons (AAOS) presided over the Academy during a transformative time accelerated by COVID-19. Dr. Bosco began his presidency in March 2020 just as the pandemic shut down many areas of the US impacting the healthcare system and orthopedic procedures. As Dr. Bosco prepared to turn over the reins at AAOS 2021, he spoke with SmartTRAK about his experience during the year and how the pandemic and technology are creating opportunities and accelerating trends that will change the practice of orthopedics for years to come.

To find out more, click on the following video. A link to download a complete transcript of the interview is also available below.

Download the "COVID's Silver Lining" interview transcript

SmartTRAK: Lisa Mahan here with Smart Track. Today, I have the honor to be talking to Dr. Joseph Bosco, III, outgoing president of the American Academy of Orthopedic Surgeons. Dr. Bosco, thank you for talking to me today.

Dr. Joseph Bosco: Well, thank you for having me.

Ending your term as president of AAOS must be a bit bittersweet. You've served during a challenging time with the disruption from COVID. How was it navigating through the pandemic?

Topics: Orthopedics
Continue Reading
2 min read

A Strong Recovery: Q221 Advanced Wound Care Market Recap

By Susan Paquette on 9/16/21 9:52 AM

Advanced Wound Care saw a strong recovery against a weak comparator.

For Q221, according to SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up, with all segments showing increases,

The US Wound Biologics market, comprising the vast majority of the global biologics market, includes the very competitive skin substitute or CTP (Cellular and/or Tissue-Based Products) market, the Topical Drug/Delivery category and Collagen Dressings. For Q221, the US market was up significantly, with CTPs accounting for the largest share, driven by Organogensis' substantial YoY gains. 

Among the many topics covered in detail in our comprehensive Q221 Advanced Wound Care Market Recap* are:

Topics: Wound Care
Continue Reading
3 min read

Studies Demonstrate Benefits of Custom 3D Metal Implants in Total Talus Replacement

By Nick Fitzpatrick on 9/14/21 2:26 PM

3D printing technologies continue to gain traction in total talus replacement, particularly as research demonstrates it’s an effective surgical option for patients with avascular necrosis. SmartTRAK highlights three recent studies illustrating how custom 3D printed metal implants are being used in total talus replacement surgery to restore normal joint anatomy and maintain joint range of motion.

SmartTRAK will be attending the 2021 American Orthopaedic Foot & Ankle Society Meeting in Charlotte, NC, Sept 22-25, to learn more about this technology and other advancements in foot & ankle treatment. Click for information on AOFAS and how to meet with us while in Charlotte to find out what SmartTRAK can do for you.


1) Three Dimension Printing Talar Prostheses for Total Replacement in Talar Necrosis and Collapse

    • SmartTRAK Analyst Summary:
      • A retrospective study evaluated anatomical talar replacement & clinical results of 9 patients w/ talar necrosis & collapse (TNC) using 3D printed metal talus implants and reported talar height increased 6.97mm & AOFAS hindfoot score improved 53.34mm at mean follow-up of 23.17 months. Int Orthop
    •  Conclusion:
      • The study concludes "The 3D printing patient-specific total talar prostheses allowed anatomical reconstruction in TNC. This novel treatment with 3D-printed prostheses could serve as a reliable patient-specific alternative in TNC.”

Topics: Orthopedics
Continue Reading
2 min read

SmartTRAK Hosts "The State of the Spine Market" Webinar

By Thomas Wallick on 9/13/21 9:49 AM

Register now for SmartTRAK's "The State of the Spine Market" webinar to be held on Wednesday, September 22, 2021 at 1:00 pm ET. Learn from SmartTRAK's General Manager of Spine, Julianne Burns, about the latest trends in the Spine market and how COVID-19 continues to impact the market. 

Agenda:
  • A Look Back: How COVID Impacted the Spine Market in Q1 & Q2
  • Q3 and Beyond: Dealing with Delta and More
  • Market Drivers & Trends
  • Q&A

Registration is free but limited. Sign up now to reserve your spot!

Julianne Burns, Smarttrak's General Manager, Spine, has 15+ years' experience in consulting, market development and marketing in the spine industry, including 7+ years at Medtronic Spinal & Biologics.

Continue Reading
3 min read

Know Before You Go: AOFAS 2021 in Charlotte, NC

By Thomas Wallick on 9/10/21 11:04 AM

After another difficult year, it's time to get out there and start reconnecting in person. SmartTRAK is excited to be traveling to Charlotte, NC to attend AOFAS at the Charlotte Convention Center, September 21-25.

SmartTRAK will be represented by Natasha Weeks, General Manager, Trauma & Extremities. Natasha is also managing our 3 newest modules, Pediatric Trauma, Pediatric Extremities and Pediatric Spine. If you would like to meet with Natasha while attending the meeting, just click here.

Now that we're back to in-person meetings, it's time to resume our continuing series Know Before You Go, so I sat down and asked Natasha a few questions about what she is looking forward to at AOFAS.

Continue Reading
3 min read

SmartTRAK's New Pediatric Modules: An Interview with the Analysts

By Thomas Wallick on 9/8/21 10:03 AM

We are excited to announce the addition of the full market view of Orthopedic Pediatrics (US) to the SmartTRAK platform, featuring 3 modules covering Pediatric Trauma, Pediatric Extremities and Pediatric Spine!

Natasha Weeks, General Manager, Trauma & Extremities, will be managing Pediatric Trauma & Extremities and the Spine module will be managed by Julianne Burns, General Manager, Spine.

In the following video, Lindsey Wolejko, SmartTRAK's Director of Marketing, discusses with Natasha and Julianne what's included in each new module and why we're so excited about these additions to the SmartTRAK platform. To request more information about these offerings, please click here.

Continue Reading
2 min read

Q221 Market Recap: US Surgical Matrices

By Doug Devens on 9/7/21 8:53 AM

Procedures using surgical matrices rebounded to normal levels again, with broad strength in both hernia and breast matrices.

Procedures using surgical matrices returned to approximately normal levels, though the Delta variant may make that recovery short-lived, as recently observed in Texas. The US Surgical Matrices market rebounded strongly in Q221 according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie* continued to lead the US Surgical Matrices market, with Becton Dickinson* (BD) bouncing back nearly as strongly.

Among the many topics covered in detail in our comprehensive Q221 US Surgical Matrices Market Recap* are:

Continue Reading
2 min read

Roaring Back: Q221 US Hemostats and Sealants Market Recap

By Doug Devens on 9/2/21 10:56 AM

The US market for Hemostats and Sealants came roaring back from its pandemic depths in Q221 as procedures returned to normal.  

As surgical procedures returned to approximately normal levels, the US Hemostats and Sealants market grew +51.1% YoY in Q221 according to SmartTRAK Financial Dashboard. Growth was strong across all segments and companies. However, the Delta variant may make that recovery short-lived, as recently observed in Texas.

Among the many topics covered in detail in our comprehensive Q221 US Hemostats and Sealants Market Recap* are:

Continue Reading

    Recent Articles